Yield10 Bioscience, Inc. (YTEN)
USD 0.34
(0.0%)
USD 0.34
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 2.11 Million USD | 617.69% |
| 2022 | 294 Thousand USD | 113.57% |
| 2021 | -2.16 Million USD | -1199.49% |
| 2020 | 197 Thousand USD | 116.47% |
| 2019 | -1.19 Million USD | -134.25% |
| 2018 | 3.49 Million USD | 125.9% |
| 2017 | -13.48 Million USD | -118.26% |
| 2016 | -6.17 Million USD | 49.65% |
| 2015 | -12.26 Million USD | 38.8% |
| 2014 | -20.04 Million USD | -4.36% |
| 2013 | -19.2 Million USD | -31.82% |
| 2012 | -14.57 Million USD | 31.51% |
| 2011 | -21.27 Million USD | -69.86% |
| 2010 | -12.52 Million USD | -15.83% |
| 2009 | -10.81 Million USD | 58.72% |
| 2008 | -26.19 Million USD | -15.46% |
| 2007 | -22.68 Million USD | 9.91% |
| 2006 | -25.18 Million USD | -1321.06% |
| 2005 | -1.77 Million USD | 33.69% |
| 2004 | -2.67 Million USD | 0.0% |
| 2002 | - USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 2.05 Million USD | 43.71% |
| 2024 Q1 | 1.43 Million USD | -32.23% |
| 2023 Q4 | 2.11 Million USD | 315.35% |
| 2023 Q1 | 703 Thousand USD | 139.12% |
| 2023 FY | 2.11 Million USD | 617.69% |
| 2023 Q3 | 508 Thousand USD | -56.32% |
| 2023 Q2 | 1.16 Million USD | 65.43% |
| 2022 Q4 | 294 Thousand USD | 127.32% |
| 2022 FY | 294 Thousand USD | 113.57% |
| 2022 Q1 | 974 Thousand USD | 144.97% |
| 2022 Q2 | -200 Thousand USD | -120.53% |
| 2022 Q3 | -1.07 Million USD | -438.0% |
| 2021 Q1 | -15 Million USD | -7718.27% |
| 2021 FY | -2.16 Million USD | -1199.49% |
| 2021 Q4 | -2.16 Million USD | 80.76% |
| 2021 Q3 | -11.25 Million USD | 7.64% |
| 2021 Q2 | -12.18 Million USD | 18.78% |
| 2020 Q2 | 594 Thousand USD | 291.61% |
| 2020 Q4 | 197 Thousand USD | -76.32% |
| 2020 Q3 | 832 Thousand USD | 40.07% |
| 2020 FY | 197 Thousand USD | 116.47% |
| 2020 Q1 | -310 Thousand USD | 74.08% |
| 2019 Q4 | -1.19 Million USD | -139.67% |
| 2019 Q3 | 3.01 Million USD | 7.33% |
| 2019 Q2 | 2.8 Million USD | 1290.59% |
| 2019 Q1 | 202 Thousand USD | -94.22% |
| 2019 FY | -1.19 Million USD | -134.25% |
| 2018 Q3 | -3.3 Million USD | -48.45% |
| 2018 Q4 | 3.49 Million USD | 205.63% |
| 2018 Q2 | -2.22 Million USD | 66.31% |
| 2018 Q1 | -6.61 Million USD | 50.97% |
| 2018 FY | 3.49 Million USD | 125.9% |
| 2017 Q2 | -1.94 Million USD | 48.53% |
| 2017 FY | -13.48 Million USD | -118.26% |
| 2017 Q4 | -13.48 Million USD | -604.39% |
| 2017 Q3 | -1.91 Million USD | 1.49% |
| 2017 Q1 | -3.77 Million USD | 38.89% |
| 2016 Q2 | -3.7 Million USD | 29.65% |
| 2016 Q3 | -9.78 Million USD | -163.81% |
| 2016 Q4 | -6.17 Million USD | 36.85% |
| 2016 FY | -6.17 Million USD | 49.65% |
| 2016 Q1 | -5.27 Million USD | 57.04% |
| 2015 Q2 | -22.7 Million USD | -71.28% |
| 2015 FY | -12.26 Million USD | 38.8% |
| 2015 Q1 | -13.25 Million USD | 33.87% |
| 2015 Q3 | -17.89 Million USD | 21.2% |
| 2015 Q4 | -12.26 Million USD | 31.44% |
| 2014 Q2 | -5.53 Million USD | -53.38% |
| 2014 FY | -20.04 Million USD | -4.36% |
| 2014 Q1 | -3.6 Million USD | 81.23% |
| 2014 Q3 | -25.48 Million USD | -360.78% |
| 2014 Q4 | -20.04 Million USD | 21.35% |
| 2013 Q3 | -8.87 Million USD | 71.99% |
| 2013 Q4 | -19.2 Million USD | -116.51% |
| 2013 Q2 | -31.67 Million USD | 15.99% |
| 2013 Q1 | -37.7 Million USD | 13.85% |
| 2013 FY | -19.2 Million USD | -31.82% |
| 2012 FY | -14.57 Million USD | 31.51% |
| 2012 Q3 | -47.82 Million USD | 0.7% |
| 2012 Q2 | -48.16 Million USD | -401.47% |
| 2012 Q1 | -9.6 Million USD | 54.86% |
| 2012 Q4 | -43.77 Million USD | 8.47% |
| 2011 Q3 | -17.39 Million USD | 12.06% |
| 2011 FY | -21.27 Million USD | -69.86% |
| 2011 Q4 | -21.27 Million USD | -22.34% |
| 2011 Q2 | -19.77 Million USD | 1.34% |
| 2011 Q1 | -20.04 Million USD | -60.04% |
| 2010 Q2 | -14.16 Million USD | -2.64% |
| 2010 Q4 | -12.52 Million USD | 13.21% |
| 2010 Q1 | -13.8 Million USD | -27.63% |
| 2010 Q3 | -14.43 Million USD | -1.87% |
| 2010 FY | -12.52 Million USD | -15.83% |
| 2009 Q2 | -9.31 Million USD | 30.47% |
| 2009 Q4 | -10.81 Million USD | -10.63% |
| 2009 FY | -10.81 Million USD | 58.72% |
| 2009 Q3 | -9.77 Million USD | -4.95% |
| 2009 Q1 | -13.39 Million USD | 48.86% |
| 2008 FY | -26.19 Million USD | -15.46% |
| 2008 Q1 | -35.65 Million USD | -57.17% |
| 2008 Q4 | -26.19 Million USD | 4.01% |
| 2008 Q2 | -22.1 Million USD | 38.01% |
| 2008 Q3 | -27.28 Million USD | -23.47% |
| 2007 Q4 | -22.68 Million USD | -9.58% |
| 2007 Q2 | -9.03 Million USD | 54.51% |
| 2007 Q1 | -19.86 Million USD | 21.13% |
| 2007 FY | -22.68 Million USD | 9.91% |
| 2007 Q3 | -20.7 Million USD | -129.17% |
| 2006 FY | -25.18 Million USD | -1321.06% |
| 2006 Q2 | -15.21 Million USD | -2245.16% |
| 2006 Q3 | -6.18 Million USD | 59.34% |
| 2006 Q4 | -25.18 Million USD | -307.15% |
| 2006 Q1 | -648.6 Thousand USD | 63.4% |
| 2005 FY | -1.77 Million USD | 33.69% |
| 2005 Q4 | -1.77 Million USD | 0.0% |
| 2004 Q4 | -2.67 Million USD | 0.0% |
| 2004 FY | -2.67 Million USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Bioceres Crop Solutions Corp. | 215.18 Million USD | 99.019% |
| Muliang Viagoo Technology, Inc. | 1.08 Million USD | -93.637% |
| N2OFF, Inc. | -4.39 Million USD | 147.962% |
| Arcadia Biosciences, Inc. | -5.51 Million USD | 138.287% |